Opportunistic prostate cancer screening can lead to overdiagnosis of indolent diseases and invasive procedures. A cohort ...

URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its relationship with Novant Health as a designated vendor for its SUREcore and ...

Investigators tested a new neoadjuvant immunotherapy to fight prostate cancer using a virus-mimicking drug to activate the immune system.

Bone marrow metastasis (BMM) from non-hematolymphoid malignancies with resultant cytopenia(s) can mimic primary hematolymphoid disorders. This study ...

Various imaging modalities show low sensitivity for detecting pelvic lymph node invasion prior to surgery in patients with intermediate risk prostate cancer.

Researchers assess the adequacy of tissue ablation by a cooled laser therapy in patients with localized prostate cancer.

Robotic-assisted transperineal fusion biopsy led to relatively low rates of prostate cancer upgrading and downgrading in a ...

He said AI is already being used in hematology analysers, histopathology, cytopathology, prostate biopsies, lung cancer, breast cancer, lymph node metastasis, and urine and fluid examinations, with ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Driven by the rising global cancer burden, aging populations, and rapid adoption of AI-powered digital pathology, the ...

A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published in Annals of Internal Medicine indicated.“We have developed a tool that can ...